Kura Oncology, Inc.

New phase 1 trial NCT06026410 posted by Kura Oncology, Inc.: "KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 92 days ago.

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.